February 5, 2010, NIH Record, Vol. LXII, No. 3

Total Page:16

File Type:pdf, Size:1020Kb

February 5, 2010, NIH Record, Vol. LXII, No. 3 FEBRUARY 5, 2010 The Second Best Thing About Payday VOL. LXII, NO. 3 The Revolution Continues Green Offers Tour of Genomic Landscape, Circa 2010 By Rich McManus ABOVE · NIAID’s Alonda LeCounte sacrificed a kidney to benefit her stepfather. See story here is a good reason that Lipsett on p. 7. TAmphitheater was jammed with at- features tendees as NHGRI began its modestly titled Current Topics in Genome Analysis 1 course—an institute staple since 1995— Green Presents Challenges of Genomic Medicine on Jan. 12. The 11-lecture series that ends Mar. 23 was launched by NHGRI di- 3 rector Dr. Eric Green, who in 90 minutes Greider Explains Science Behind Her Nobel Prize surveyed highlights of what mankind has learned of its genetic heritage start- 5 ing before Mendel (1865) to the present. Harvard’s Frenk Lectures on Global Health A postdoctoral fellow at the outset of the Human Genome Project in 1990, NHGRI director Dr. Eric Green 7 Green offered a robust primer of a field NIAID Employee’s Generosity Offers that literally exploded during the “genomic revolution” of the 1990s. Having a front- Stepfather New Life row seat at what is arguably the most significant scientific endeavor of the past century 12 gives Green both authority and a rich fund of metaphor: the 3 billion base pairs NHGRI Fellow Plays with ‘Rock Stars see genome, page 6 Of Science’ Anything Is Possible Nobelist Nirenberg, MIT’s Herr Works to Discoverer of the Make Physical Genetic Code, departments Disabilities a Thing Mourned Of the Past By Alan Schechter Briefs 2 By Valerie Lambros Milestones 9 Dr. Marshall Warren NIMH’s Innova- Nirenberg, who discov- Digest 10 tion Speaker Series ered the genetic code Feedback 11 is intended to bring used by virtually all liv- astounding people to ing organisms to trans- NIH to offer lectures, but few speakers leave late the information in DNA molecules into audiences with the feeling of awe that the protein structure, died of cancer Jan. 15 in New institute’s guest, Dr. Hugh Herr of MIT, did York after an illness of several months. His recently. work is considered one of the major milestones of biological research during the last century. “Some time ago, I attended a workshop and we talked about the traits of innovative, creative “Marshall’s wish to explore turned into a reve- people,” said Dr. David Armstrong of NIMH lation about biology that is almost unmatched in his introduction of Herr. “The characteristic in terms of its consequences for understanding that stuck with me most was this ability and of life,” said NIH director Dr. Francis Collins. willingness to persist and persevere even when “He was not only a scientist’s scientist, but a obstacles appear to be insurmountable. That’s mentor’s mentor...we mourn the loss of a true Hugh Herr.” scientific hero.” The NIH Record is recyclable as office white paper. Within 30 seconds of starting his talk, Herr Nirenberg’s initial contribution to solving see herr, page 4 see nirenberg, page 8 sciences in clinical research from Duke University School of Medicine. The degree requires 24 credits of graded course work, plus a research project for which 12 units of credit are given. The program is designed for part-time study, allowing the student briefs to integrate the program’s academic training with his or her clinical training. Robbins To Present DDM Seminar, Feb. 18 Applications are available in the Office of Clinical Research Training and Medical Education, Bldg. The 2009-2010 Deputy Director for Management 10, Rm. B1L403 or via email from Benita Bazemore Seminar Series,“Management and Science: at [email protected]. Additional informa- Partnering for Excellence,” continues on tion regarding coursework and tuition costs is Thursday, Feb. 18 from 11 a.m. to 12:30 p.m. available via the program web site at http://tpcr. in Masur Auditorium, Bldg. 10, with Dr. Steve mc.duke.edu. Robbins in a presentation on “Diversity and Inclusion 2.0: A 21st Century Approach.” He will Enrollment in the program is limited. Interested discuss ways to leverage diverse perspectives individuals should inquire with their NIH insti- for creativity, innovation and achievement of tute/center regarding funding for participation. organizational goals. He is the author of What Email queries about the program may be ad- If?: Short Stories to Spark Diversity Dialogue dressed to [email protected]. The deadline for and editor of Inclusion Insights. Videocasting applying is Mar. 15. Successful applicants will be and sign language will be provided. Individuals notified by July 1. who need reasonable accommodation to attend should call (301) 496-6211 or the Federal Relay NCI Offers Online Course for Health Professionals Service at 1-800-877-8339. For more information about the series, visit www.ddmseries.od.nih. The National Cancer Institute announces the avail- gov or call (301) 496-3271. ability of Including Clinical Trials in Your Practice, a new interactive, online course for oncology professionals. This free tutorial is geared toward STEP Forum on Patient Advocacy and NIH The NIH Record is published biweekly at those who are interested in incorporating clinical Bethesda, MD by the Editorial Operations The staff training in extramural programs (STEP) trials into their oncology practices. Branch, Office of Communications and Public committee will present an Administrative Strate- This new course emphasizes the importance of Liaison, for the information of employees of gies forum on the topic “Patient Advocacy & NIH: the National Institutes of Health, Department clinical trials, discusses challenges trial investiga- of Health and Human Services. The content is Marriage by Choice or Necessity?” on Tuesday, tors face and offers solutions. It is a narrated tutorial reprintable without permission. Pictures may Feb. 9, from 8:30 a.m. to 12:30 p.m. in Natcher consisting of 8 modules and includes case studies be available upon request. Use of funds for conference center, Rms. E1/E2. and exercises to enhance the user experience. printing this periodical has been approved by the director of the Office of Management and The role of patient advocacy groups in promot- With this course, oncologists will understand the Budget through September 30, 2010. ing public health issues has been controversial. process and steps involved in weaving NCI- Growing from social movement advocacy To receive alerts to our latest issue, send an sponsored clinical trials into their practice. It can for faster development of AIDS treatments also serve as an orientation or a refresher on best email to [email protected] with the words to current public-private partnerships, the “Subscribe NIHRECORD” in the message body. practices. relationship between NIH and patient advocates NIH Record Office Bldg. 31, Rm. 5B41 has come a long way. Should the practice of To access the course, see www.cancer.gov/clinical- Phone (301) 496-2125 Fax (301) 402-1485 involving advocates in NIH activities become trialscourse?cid=ctcourse_record. Web address http://nihrecord.od.nih.gov more commonplace? How and when should they serve as consultants for clinical research, in peer Editor Sailing Association Open House, Feb. 25 review or as program advisors to the institutes Richard McManus The NIH Sailing Association invites everyone to its [email protected] and centers? This STEP forum will discuss ways to facilitate working with advocacy groups and open house on Thursday, Feb. 25 from 5 to 8 p.m. at Assistant Editor explore the benefits to NIH staff, scientists, the FAES House at the corner of Old Georgetown Rd. Carla Garnett advocates and, most importantly, patients. and Cedar Ln. Would you like to learn to sail? Can [email protected] you imagine being part of a group of skilled sailing Staff Writers instructors, enthusiasts and boat owners? The club NIH-Duke Training Program in Clinical Research Jan Ehrman offers instruction, sailboats for charter, racing, [email protected] Applications are being accepted for the cruises, parties and fun. Open house is $5 at the Valerie Lambros 2010-2011 NIH-Duke Training Program in door and includes pizza and sodas; cash bar for [email protected] Clinical Research. Implemented in 1998, the beer and wine, $1 each. Look for NIHSA posters and The NIH Record reserves the right to make program is designed primarily for physicians flyers around campus. For more information, visit corrections, changes or deletions in submitted and dentists who desire formal training in the www.recgov.org/sail. copy in conformity with the policies of the quantitative and methodological principles of paper and HHS. clinical research. Courses are offered at the Clinical Center via videoconference technology. Academic credit earned by participating in this program may be applied toward satisfying the degree requirement for a master of health 2 2 FEBRUARY 5, 2010 FEBRUARY 5, 2010 VOL. LXII, NO. 3 graduate school at the University of California, Berkeley. Hudson shared photos and humor- ous stories of Greider from that period. To the crowd’s delight, she also Above, NHGRI director Dr. Eric Green and NIH had pictures of the Nobel chief of staff Dr. Kathy Hudson (r) welcome Nobel Prize ceremony, which Prize winner Dr. Carol Greider to NIH. At right, she attended as a guest of Greider, an expert on telomerase, delivers NHGRI’s Greider’s. annual Trent Lecture. “When I told a friend at photos: bill branson NIH that I was going to miss a meeting because 2009 Nobel Laureate Greider Delivers I had to go to Stockholm, she said I have the best girlfriend story ever...my Trent Lecture friend won the Nobel Prize,” Hudson said. Nobel Prize winner Dr. Carol Greider present- Greider then took the podium.
Recommended publications
  • Download Ps Nobel Prizes for Site BEE 11.18.16 Revised 11.30.17.Pdf
    Nobel Laureates at the College of Physicians and Surgeons For years, College of Physicians and Surgeons alumni, faculty, and researchers have led groundbreaking clinical and basic scientific studies that have transformed our understanding of human biology and advanced the practice of medicine. On many occasions, this work has been honored with the Nobel Prize. The scope of research led by P&S Nobel laureates is tremendous. Although most of our prizewinners were honored for work in physiology or medicine, a few also received the prize for chemistry. Their research has fundamentally shaped the course of numerous fields, including cardiology, neuroscience, genetics, pharmaceutical development, and more. Our Nobel laureates include: André Cournand and Dickinson Richards (P&S’23), whose work at P&S on cardiac catheterization—a method of inserting a tiny tube into the heart—provided the basis for open-heart surgery and interventional cardiology Baruch Blumberg (P&S’51), who discovered the hepatitis B virus and helped develop a test and a vaccine for the virus Joshua Lederberg, a Columbia College and P&S graduate student who showed that bacteria can exchange genes when they reproduce, creating a way to model and study genetics in higher organisms Harold Varmus (P&S’66), who demonstrated how genes in normal human and animal cells can mutate to cause cancer, leading to a new generation of research on the genetic origins of cancer Eric Kandel, current University Professor, who showed how memories are stored in nerve cells, greatly enhancing
    [Show full text]
  • Biographical Notes on Scientists Involved in the Asilomar Process M.J
    International Dimensions of Ethics Education in Science and Engineering Case Study Series: Asilomar Conference on Laboratory Precautions Appendix D: Biographical Notes on Scientists involved in the Asilomar Process M.J. Peterson Version 1, June 2010 Edward A. Adelberg (1920-2009). PhD Yale 1949. Chair of Yale Department of Microbiology 1961-64 and 1970-72; a founding member of Yale Department of Genetics. Deputy Provost for the Biomedical Sciences, 1983-91. Specialist in plasmid biochemistry of E. coli. Ephraim Anderson (1911-2006). M.D., Durham University. Served in the Royal Army Medical Corps during World War II where he developed interests in Epidemiology. Researcher in Enteric Laboratory of the British Public Health Laboratory Service 1947, Deputy Director 1952, Director 1954-1978. Came to public notice for tracing sources of typhoid outbreaks in Zermatt (1963) and Aberdeen (1964). Built on earlier work by Japanese researchers to demonstrate the plasmid-based pathways by which bacteria could spread antibiotic resistance to others and became the world’s leading expert on antibiotic resistance. Also prominent in efforts to limit use of antibiotics in raising animals. Fellow of the Royal Society 1968; Companion of the Order of the British Empire 1976. Eric Ashby, Baron Ashby (1904-1992). Lecturer in Botany, Imperial College London 1931-35; Reader in Botany Bristol University 1935-37; Professor of Botany University of Sydney 1938-1946; Chair of Botany, University of Manchester 1947-50. Turned to administration as President and Vice-Chancellor of Queen's University, Belfast 1950-59; Master of Clare College in Cambridge University 1959-67 and Vice-Chancellor of Cambridge University 1967-1969.
    [Show full text]
  • Balcomk41251.Pdf (558.9Kb)
    Copyright by Karen Suzanne Balcom 2005 The Dissertation Committee for Karen Suzanne Balcom Certifies that this is the approved version of the following dissertation: Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine Committee: E. Glynn Harmon, Supervisor Julie Hallmark Billie Grace Herring James D. Legler Brooke E. Sheldon Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine by Karen Suzanne Balcom, B.A., M.L.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2005 Dedication I dedicate this dissertation to my first teachers: my father, George Sheldon Balcom, who passed away before this task was begun, and to my mother, Marian Dyer Balcom, who passed away before it was completed. I also dedicate it to my dissertation committee members: Drs. Billie Grace Herring, Brooke Sheldon, Julie Hallmark and to my supervisor, Dr. Glynn Harmon. They were all teachers, mentors, and friends who lifted me up when I was down. Acknowledgements I would first like to thank my committee: Julie Hallmark, Billie Grace Herring, Jim Legler, M.D., Brooke E. Sheldon, and Glynn Harmon for their encouragement, patience and support during the nine years that this investigation was a work in progress. I could not have had a better committee. They are my enduring friends and I hope I prove worthy of the faith they have always showed in me. I am grateful to Dr.
    [Show full text]
  • Members of Groups Central to the Scientists' Debates About Rdna
    International Dimensions of Ethics Education in Science and Engineering Case Study Series: Asilomar Conference on Laboratory Precautions Appendix C: Members of Groups Central to the Scientists’ Debates about rDNA Research 1973-76 M.J. Peterson Version 1, June 2010 Signers of Singer-Söll Letter 1973 Maxine Singer Dieter Söll Signers of Berg Letter 1974 Paul Berg David Baltimore Herbert Boyer Stanley Cohen Ronald Davis David S. Hogness Daniel Nathans Richard O. Roblin III James Watson Sherman Weissman Norton D. Zinder Organizing Committee for the Asilomar Conference David Baltimore Paul Berg Sydney Brenner Richard O. Roblin III Maxine Singer This case was created by the International Dimensions of Ethics Education in Science and Engineering (IDEESE) Project at the University of Massachusetts Amherst with support from the National Science Foundation under grant number 0734887. Any opinions, findings, conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. More information about the IDEESE and copies of its modules can be found at http://www.umass.edu/sts/ethics. This case should be cited as: M.J. Peterson. 2010. “Asilomar Conference on Laboratory Precautions When Conducting Recombinant DNA Research.” International Dimensions of Ethics Education in Science and Engineering. Available www.umass.edu/sts/ethics. © 2010 IDEESE Project Appendix C Working Groups for the Asilomar Conference Plasmids Richard Novick (Chair) Royston C. Clowes (Institute for Molecular Biology, University of Texas at Dallas) Stanley N. Cohen Roy Curtiss III Stanley Falkow Eukaryotes Donald Brown (Chair) Sydney Brenner Robert H. Burris (Department of Biochemistry, University of Wisconsin) Dana Carroll (Department of Embryology, Carnegie Institution, Baltimore) Ronald W.
    [Show full text]
  • Restriction Enzymes and the Boon to Modern Molecular Biology
    PNAS CLASSIC PAPER Danna and Nathans: Restriction enzymes and the boon to modern molecular biology n 1971, a paper published in PNAS proteins and viral RNA. Although he time,’’ said Danna, currently an associ- (1) helped jump-start the era of never obtained a Ph.D., the work gave ate professor at the University of Colo- modern molecular biology and bio- him confidence and experience with bio- rado (Boulder). ‘‘You would try hard to technology, eventually giving rise to chemistry, leading to a faculty position solve a problem and then go to him if Imany of the genetic advances that seem so in the microbiology department at The you needed help.’’ commonplace today. The article, written Johns Hopkins University School of by Academy member Daniel Nathans and Medicine (Baltimore) in 1962. In A Clear Vision his then graduate student, Kathleen Nathans’ own words, he became ‘‘a one- Smith and his postdoctoral student Kelly Danna, exposed the marvelous utility of man ‘Division of Genetics’ ’’ (3), which made rapid progress with their indepen- restriction enzymes. In the accompanying gradually morphed into a sizable group, dent study of the Hemophilus influenzae Perspective highlighting this classic work including graduate student Kathleen restriction enzyme, concluding in 1970 of scientific literature, Rich Roberts pro- Danna, fellow professor Hamilton O. that the enzyme cleaved DNA only at vides a historical account of the scientific Smith, and Smith’s postdoctoral student sites with a specific arrangement of base discoveries leading up to the PNAS paper Thomas Kelly. This combination of tal- pairs. However, after publishing their and the unparalleled scientific advances ents would prove highly fruitful in the findings (4), the scientists abandoned made after its publication.
    [Show full text]
  • Daniel Nathans 1928–1999
    NATIONAL ACADEMY OF SCIENCES DANIEL NATHANS 1928–1999 A Biographical Memoir by DANIEL DIMAIO Any opinions expressed in this memoir are those of the author and do not necessarily reflect the views of the National Academy of Sciences. Biographical Memoirs, VOLUME 79 PUBLISHED 2001 BY THE NATIONAL ACADEMY PRESS WASHINGTON, D.C. Photo by Arthur Kravetz, Baltimore, Maryland DANIEL NATHANS October 30, 1928–November 16, 1999 BY DANIEL DIMAIO ANIEL NATHANS, A SCIENTIST whose pioneering use of D restriction endonucleases revolutionized virology and genetics and whose personal qualities had a profound impact on those who knew him, passed away in November 1999 at the age of 71. He was the University Professor of Molecular Biology and Genetics at the Johns Hopkins University School of Medicine, where he served on the faculty for 37 years, and a senior investigator of the Howard Hughes Medical Institute since 1982. Dan is survived by his wife, Joanne; three sons, Eli, Jeremy, and Benjamin; and seven grand- children. Dan was born and raised in Wilmington, Delaware, the youngest of eight children of Russian Jewish immigrants. He attended the University of Delaware, initially living at home and commuting by hitchhiking, and graduated with a degree in chemistry in 1950. He then entered medical school at Washington University in St. Louis, largely because, he claimed, his father saw him “as the last chance to have a doctor in the family.” Dan began medical school with the intention of returning to Wilmington as a general practitioner, but a summer job in a local hospital bored him and made him rethink these plans and return early to St.
    [Show full text]
  • The Clinical Investigator: Bewitched, Bothered, and Bewildered-- but Still Beloved
    The clinical investigator: bewitched, bothered, and bewildered-- but still beloved. J L Goldstein, M S Brown J Clin Invest. 1997;99(12):2803-2812. https://doi.org/10.1172/JCI119470. Editorial Find the latest version: https://jci.me/119470/pdf The Clinical Investigator: Bewitched, Bothered, and Bewildered—But Still Beloved Editorial Joseph L. Goldstein and Michael S. Brown Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9046 Editor’s note: It is a difficult time for “physician-scien- model is threatened. The threat comes not from the basic side. tists.” The increasing specialization of science on one To the contrary, basic research is flourishing as never before. hand and the financial demands of managed care on the Rather, the threat comes from the failure of the cadre of physi- other are forcing a reconsideration of the role and impor- cian-scientists to grow in proportion to the numbers in basic tance of these individuals. Are they a dying breed? Or research. Indeed, this cadre is shrinking as young physicians are they merely being redefined? In this editorial, Joseph are forced to choose between performing research or practic- Goldstein and Michael Brown of the University of Texas ing medicine, but not both. In this article we highlight both the Southwestern Medical Center in Dallas describe their achievements and challenges faced by the physician-scientist, reading of the plight of the physician-scientist, and offer a and we propose steps that may solve some of the problems. suggestion how this beleaguered species might be saved. We begin with a consideration of Shannon’s multifaceted ca- We plan to continue this discussion in the pages of JCI reer, which exemplifies the highest aspirations of his model.
    [Show full text]
  • Original 1974 Paul Berg Et Al. Call for Caution with Recombinant
    Potential Biohazards of Recombinant DNA Molecules Author(s): Paul Berg, David Baltimore, Herbert W. Boyer, Stanley N. Cohen, Ronald W. Davis, David S. Hogness, Daniel Nathans, Richard Roblin, James D. Watson, Sherman Weissman and Norton D. Zinder Source: Science, New Series, Vol. 185, No. 4148 (Jul. 26, 1974), p. 303 Published by: American Association for the Advancement of Science Stable URL: http://www.jstor.org/stable/1738673 Accessed: 27-08-2015 20:21 UTC Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at http://www.jstor.org/page/ info/about/policies/terms.jsp JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship. For more information about JSTOR, please contact [email protected]. American Association for the Advancement of Science is collaborating with JSTOR to digitize, preserve and extend access to Science. http://www.jstor.org This content downloaded from 128.163.2.206 on Thu, 27 Aug 2015 20:21:36 UTC All use subject to JSTOR Terms and Conditions LETTERS minimize the spread of such molecules within human and other populations; Potential Biohazards of Sciences give consideration to these and (iii) devising guidelines to be matters. The undersigned members of followed by investigators with Recombinant DNA Molecules working a committee, acting on behalf of and potentially hazardous recombinant with the endorsement of the DNA Recent advances in techniques for Assembly molecules.
    [Show full text]
  • HARRY NOLLER, Ph. D. Harry Noller Was Born in Oakland, California, and Received His Undergraduate Training in Biochemistry at UC, Berkeley
    HARRY NOLLER, Ph. D. Harry Noller was born in Oakland, California, and received his undergraduate training in biochemistry at UC, Berkeley. He did his graduate work on the mechanism of action of serine proteases under Sidney Bernhard in the Institute of Molecular Biology at the University of Oregon, where he received his Ph.D. in Chemistry in 1965. He was an NIH Postdoctoral Fellow at the MRC Laboratory of Molecular Biology in Cambridge, where he carried out proteinchemistry in the laboratory of Ieuan Harris in Fred Sanger’s department. In 1966, he joined Alfred Tissières’ laboratory for his second postdoc in the newly formed Dèpartement de Biochimie Genètique in the Institute de Biologie Molèculaire at the University of Geneva, where he began research on ribosomes. In 1968, he joined the faculty of the University of California, Santa Cruz, where he is currently Sinsheimer Professor of Molecular Biology, Professor of Molecular, Cell and Developmental Biology and Director of the Center for Molecular Biology of RNA. Intending to study the functional roles of the ribosomal proteins by biochemical approaches, experiments in Noller’s lab in the early 1970s pointed unexpectedly to a key functional role for ribosomal RNA. This unanticipated change in direction led to many studies over the following decades directed toward understanding the structure of ribosomal RNA and its functional roles in translation. Among these were the sequencing of the rrnB operon containing the first complete 16S and 23S ribosomal RNA sequences, and, in collaboration with Carl Woese, deducing their secondary structures by comparative sequence analysis. Genetic studies on rRNA in the Noller lab, using vectors based on the rrnB operon, showed that mutations in rRNA could confer severe functional phenotypes such as increased translational error frequencies and defects in tRNA binding.
    [Show full text]
  • Nobel Laureates in Physiology Or Medicine
    All Nobel Laureates in Physiology or Medicine 1901 Emil A. von Behring Germany ”for his work on serum therapy, especially its application against diphtheria, by which he has opened a new road in the domain of medical science and thereby placed in the hands of the physician a victorious weapon against illness and deaths” 1902 Sir Ronald Ross Great Britain ”for his work on malaria, by which he has shown how it enters the organism and thereby has laid the foundation for successful research on this disease and methods of combating it” 1903 Niels R. Finsen Denmark ”in recognition of his contribution to the treatment of diseases, especially lupus vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science” 1904 Ivan P. Pavlov Russia ”in recognition of his work on the physiology of digestion, through which knowledge on vital aspects of the subject has been transformed and enlarged” 1905 Robert Koch Germany ”for his investigations and discoveries in relation to tuberculosis” 1906 Camillo Golgi Italy "in recognition of their work on the structure of the nervous system" Santiago Ramon y Cajal Spain 1907 Charles L. A. Laveran France "in recognition of his work on the role played by protozoa in causing diseases" 1908 Paul Ehrlich Germany "in recognition of their work on immunity" Elie Metchniko France 1909 Emil Theodor Kocher Switzerland "for his work on the physiology, pathology and surgery of the thyroid gland" 1910 Albrecht Kossel Germany "in recognition of the contributions to our knowledge of cell chemistry made through his work on proteins, including the nucleic substances" 1911 Allvar Gullstrand Sweden "for his work on the dioptrics of the eye" 1912 Alexis Carrel France "in recognition of his work on vascular suture and the transplantation of blood vessels and organs" 1913 Charles R.
    [Show full text]
  • Proceedings of the American Philosophical Society Vol. 120, Num
    Proceedings of the American Philosophical Society Vol. 120, Num. 1. Año 1976 Held at Philadelphia for Promoting Useful Knowledge Fred L. Whipple. “Comet Kohoutek in Retrospect” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 1-6 Myron P. Gilmore. “The Berensons and Villa I Tatti” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 7-12 Helen B. Taussig. “The Development of the Blalock-Taussing Operation and Its Results Twenty Years Later” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 13-20 Ward H. Goodenough. “On the Origin of Matrilineal Clans: A “Just So” Story” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 21-36 Leon N. Cooper. “How Possible Becomes Actual in the Quantum Theory” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 37-45 John Owen King. “Labors of the Estranged Personality: Josiah Royce on “The Case of John Bunyan”” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 46-58 Stanley A. Czarnik. “The Theory of the Mesolithic in European Archaeology” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 59-66 Proceedings of the American Philosophical Society Vol. 120, Num. 2. Año 1976 Held at Philadelphia for Promoting Useful Knowledge Jonathan E. Rhoads. “New Approaches in the Study of Neoplasia: Preliminary Remarks for the Symposium” Proceedings of the American Philosophical Society. Vol. 120, Num. 2. Año 1976; pagina 67-68 Sol Spiegelman. “The Search for Viruses in Human Cancer” Proceedings of the American Philosophical Society.
    [Show full text]
  • Dr. Norton Zinder] Judith N
    Rockefeller University Digital Commons @ RU Rockefeller University Research Profiles Campus Publications Winter 1987 A Fine Playground: [Dr. Norton Zinder] Judith N. Schwartz Follow this and additional works at: http://digitalcommons.rockefeller.edu/research_profiles Part of the Life Sciences Commons Recommended Citation Schwartz, Judith N., "A Fine Playground: [Dr. Norton Zinder]" (1987). Rockefeller University Research Profiles. Book 27. http://digitalcommons.rockefeller.edu/research_profiles/27 This Article is brought to you for free and open access by the Campus Publications at Digital Commons @ RU. It has been accepted for inclusion in Rockefeller University Research Profiles by an authorized administrator of Digital Commons @ RU. For more information, please contact [email protected]. THE ROCKEFELLER UNIVERSITY "Al! depends on keeping the eye steadily fixed on the facts of nature, and so receiving their images as they are. For God forbid that we should give out a dream ofour own imagination RESEARCH for a pattern ofthe world. " FRANCIS BACON PROFILES WINTER 1987-88 A Fine Playground Bacteriophages - "bacteria eaters" - are tiny viruses that make their living by infecting bacteria. The late Max Delbriick, one of the pioneers of molecular biology, described bacterio­ phage research as "a fine playground for serious children who ask ambitious questions." In 1952 Norton Zinder, a graduate student at the University of Wisconsin, reported in his doctoral dissertation that bac­ teriophages can pick up genes from one bacterium and deposit them in another. Molecular biology was in its infancy. The identification ofDNA as the genetic material had been reported only eight years earlier and was still being debated. Watson and Crick had yet to build a model ofthe double helix structure of DNA.
    [Show full text]